Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Billionaire Investors Love These Five Dividend Stocks

Page 1 of 2

Billionaires represent a particularly interesting type of investor, mainly because they have much better skills at picking stocks and vast experience, which justify their large fortunes. At Insider Monkey we follow over 40 funds that are managed or founded by investors that became billionaires and we think it’s a good idea to look at their favorite picks, such as the five stocks that billionaire quants like, many of which can generate substantial gains over the long-term. With this in mind, we have identified five stocks with dividend yields above 2%, in which at least 12 billionaire investors held long positions at the end of June. All of these companies are well known and don’t require in-depth analysis, but let’s take a look at what billionaires think about them and whether or not the overall hedge fund industry agrees with their stances.


Even though investing in large-cap dividend stocks is a safe way to obtain solid returns over the long-term, it is not the best way to beat the market. We have determined that the 50 most popular stocks among hedge funds, which mostly consist of large- and mega-cap stocks, underperformed the market on average by seven basis points per month in our backtests covering the period of 1999-to-2012. On the other hand, the 15 most popular small-caps among these investors generated returns around 95 basis points above the market (see more details about our backtests). In this way, our strategy that involves following these 15 stocks, has returned 102% since August 2012, beating the S&P 500 ETF (SPY) by some 53 percentage points.

Surprisingly, dividend stocks did not rank among the most popular picks of billionaires. For example, in Allergan PLC (NYSE:AGN), which ranked on the first spot, 24 funds managed by billionaire investors reported long positions, while in Dow Chemical Co (NYSE:DOW), which is their favorite dividend stock, only 13 funds held stakes in it at the end of June. Dan Loeb, Daniel S. Och, and Larry Robbins are only a few of the investors that are bullish on Dow Chemical. The company pays a dividend of $0.42, which gives its stock a yield of 3.53%, one of the highest among large-cap chemical stocks. Dan Loeb‘s Third Point held the largest stake in Dow Chemical Co (NYSE:DOW) among the funds we track, disclosing ownership of 23 million shares as of the end of June. Overall, hedge funds that we follow are bullish on Dow Chemical Co (NYSE:DOW), as 65 of them reported positions equal to almost 10% of the company’s shares.

Follow Dow Chemical Co (INDEXDJX:DOW)

Microsoft Corporation (NASDAQ:MSFT) comes next, as its stock trails a dividend yield of 3.06%. A total of 14 billionaires held stakes in the tech giant with an aggregate value of $7.14 billion. Microsoft Corporation (NASDAQ:MSFT) was also one of the top picks among hedge funds from our database, being included in the equity portfolios of 107 investors. Billionaire Jeff Ubben‘s ValueAct Capital is by far the largest shareholder of Microsoft Corporation (NASDAQ:MSFT) in our database, owning 75.27 million shares. The fund also has a representative on the company’s board of directors.

Follow Microsoft Corp (NASDAQ:MSFT)
Trade (NASDAQ:MSFT) Now!

Three more dividend stocks popular among the world’s wealthiest investors can be found on the following page.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!